Health Products

ARCHITECT Hemoglobin A1c (2017-12-21)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
50007UQ10
Manufacturer
Abbott Laboratories Diagnostcis Division
100 Abbott Park Road
Abbott Park
60064
Illinois
UNITED STATES
ARCHITECT Hemoglobin A1c4P52-21

Introduction

Affected products

ARCHITECT Hemoglobin A1c

Reason

It was identified that interference from fetal hemoglobin (HbF) occurs at a level lower than what is stated in the ARCHITECT Hemoglobin A1c (ln 4p52-21) package insert. The package insert indicates that the Hemoglobin A1c (HbA1c) assay is susceptible to interference effects from HbF at > 20%, while the most current data shows interference at HbF at > 5%. All in-date lots of ln 4p52-21 reagent inventory are impacted.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime